The Virginia G. Piper Cancer Center at Scottsdale Healthcare and the Translational Genomics Research Institute (TGen) are studying the safety and effectiveness of a new drug, AG-120, for treatment of patients with solid tumors, ...
Jun 17, 2014
0
1
Researchers at the Translational Genomics Research Institute (TGen) and physicians at Mayo Clinic's Individualized Medicine Clinic have personalized drug treatments for patients with cholangiocarcinoma using genomic sequencing ...
Feb 14, 2014
0
0
Singapore-led scientific team discovers critical genes in bile duct cancers from different parts of the world. New molecular insights point to potentially different treatment regimens for the same cancer type depending on ...
Nov 3, 2013
0
0
GW Researchers, Jeffrey M. Bethony, Ph.D., associate professor of Microbiology, Immunology, and Tropical Medicine, and Paul Brindley, Ph.D., professor of Microbiology, Immunology, and Tropical Medicine at GW School of Medicine ...
May 29, 2012
0
0
(Medical Xpress) -- A combined team of scientists from Singapore and Thailand has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. Using the latest genomic technologies, ...
May 9, 2012
0
0
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited. ...
Jan 18, 2012
0
0
